XML 22 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
 12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net income (loss) $ 62,834 $ (1,386,168)
Adjustments to reconcile net income (loss) to net cash used by operating activities:    
Stock based compensation 639,631 56,533
Restricted stock expense 39,100 156,400
Amortization of debt issue costs 0 305,800
Depreciation and amortization 222,546 71,276
Issuance of stock / warrants for services 496,502 627,825
Other-than-temporary impairment on marketable securities 0 175,000
Debt conversion expense 0 446,250
Inventory / marketing material impairment 262,343 67,226
Intangible impairment 240,000 0
Accounts receivable impairment 0 50,000
Loss on sale of property and equipment 69,311 4,000
Common stock issued as charitable contribution 0 17,000
Non-cash consideration received for services provided (3,404,502) (1,932,552)
Changes in operating assets and liabilities:    
Accounts receivable (499,373) (27,488)
Accounts receivable - related party (492,577) (712,325)
Other accounts receivable (1,890,434) (12,440)
Other accounts receivable - related party 236,364 (36,364)
Note receivable (459,000) 0
Note receivable - related party 120,228 (1,375)
Inventory 255,894 (41,216)
Prepaid consulting agreement (200,000) 0
Prepaid rent (180,000) 0
Prepaid expenses and other current assets (529,335) 58,458
Accounts payable and accrued expenses 285,156 (745,252)
Accounts payable and accrued expenses - related party (951,824) 278,265
Interest Payable 0 184,889
Deferred Revenue 120,041 41,417
Deferred tax liability (16,000) 25,000
Cash used by operating activities (5,573,095) (2,329,841)
Cash flows from investing activities:    
Purchase of investment other securities 0 200,000
Purchase of other investment securities (300,000) 0
Purchase of intangible assets (360,000) 0
Purchase of property and equipment (23,559) (7,967)
Cash provided by (used by) investing activities (683,559) 192,033
Cash flows from financing activities:    
Proceeds from issuance of common stock 10,927,535 829,497
Exercise of stock options 0 3,002
Deferred issuance costs (672,574) (39,723)
Debt issuance cost 0 (200,800)
Proceeds from convertible note 0 2,125,000
Distribution related party 0 (29,180)
Repayments of line of credit 0 (300,000)
Cash provided by financing activities 10,254,961 2,387,796
Net (decrease) increase in cash 3,998,307 249,988
Cash and cash equivalents, beginning of year 284,246 34,258
Cash and cash equivalents, end of year 4,282,553 284,246
Cash Payments for:    
Interest expense 955 5,210
Non-cash financial activities:    
Equity investment exchange to be issued in the future, included in Accounts receivable other 160,000 0
Common stock issued to purchase membership interest - I'M1 0 971,667
Common stock issued to purchase membership interest - EE1 0 471,668
Non-controlling interest transfer 0 950,242
Strike price adjustment on placement agent warrants 0 31,350
Common stock issued for warrant exercise 0 38
Common Stock issued for conversion of Line of Credit 0 773,177
Common Stock issued for conversion of Promissory Notes 0 2,252,500
Deferred IPO costs acquired via issuance of payables 0 362,817
Deferred IPO costs acquired via issuance of stock/warrants 0 95,195
Distributions of stock to non-controlling interests 0 223,440
Stock and warrants issued for intangible assets 0 379,714
Fixed assets acquired through lease 0 14,983
Non-cash proceeds on sale of fixed assets 0 7,000
Intellectual property issued via issuance of payables 0 945,000
Warrants issued to IPO selling agent $ 171,600 $ 0